Acetylsalicylic Acid

Polyps

Dartmouth-Hitchcock Medical CenterPhase 2/3Dormant

B

61/ 100

Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence: 46/ 100
Competitive Position: 95/ 100

Competitive context

0 Active assets in the Polyps cohort.

Asset / Sponsor	Phase	Rating
PROPOFOL Mount Carmel Health System	Phase 4	BB
MIDAZOLAM Mount Carmel Health System	Phase 4	BB
FENTANYL Mount Carmel Health System	Phase 4	BB
MARBLE DUST Dartmouth-Hitchcock Medical Center	Phase 2/3	B
Folate Dartmouth-Hitchcock Medical Center	Phase 2/3	B

Same molecule, other indications

Acetylsalicylic Acid is also rated in:

myocardial infarctionDormant

A

Indicative ·

83 / 100

coronary artery disorderDormant

BBB

Indicative ·

79 / 100

cardiovascular disorderDormant

BBB

Indicative ·

78 / 100

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.